Cargando…

Folate Receptor Targeted Alpha-Therapy Using Terbium-149

Mostrar otras versiones (1)

Terbium-149 is among the most interesting therapeutic nuclides for medical applications. It decays by emission of short-range α-particles (Eα = 3.967 MeV) with a half-life of 4.12 h. The goal of this study was to investigate the anticancer efficacy of a 149Tb-labeled DOTA-folate conjugate (cm09) usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Cristina, Reber, Josefine, Haller, Stephanie, Dorrer, Holger, Köster, Ulli, Johnston, Karl, Zhernosekov, Konstantin, Türler, Andreas, Schibli, Roger
Lenguaje:	eng
Publicado:	2014
Materias:	Health Physics and Radiation Effects Other Fields of Physics
Acceso en línea:	https://dx.doi.org/10.3390/ph7030353 http://cds.cern.ch/record/2137140

Ejemplares similares

Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014)

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
por: Müller, Cristina, et al.
Publicado: (2016)

Terbium-149 for targeted alpha therapy
por: Borgna, Francesca, et al.
Publicado: (2021)

Terbium-149 for targeted alpha therapy
por: Grundler, Pascal, et al.
Publicado: (2023)

Targeted cancer therapy: the potential role of terbium-149
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1996)

Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2019)

Alpha-PET for Prostate Cancer: Preclinical investigation using (149)Tb-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2019)

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with $^152$Tb-DOTATOC
por: Baum, Richard P, et al.
Publicado: (2017)

Neodymium-140 DOTA-LM3: Evaluation of an In Vivo Generator for PET with a Non-Internalizing Vector
por: Severin, Gregory W., et al.
Publicado: (2017)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Dorrer, H, et al.
Publicado: (2011)

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations
por: Talip, Zeynep, et al.
Publicado: (2021)

Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
por: Borgna, Francesca, et al.
Publicado: (2021)

Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate
por: Haller, Stephanie, et al.
Publicado: (2016)

IAU Colloquium 149 : the Stellar Populations of Galaxies
por: Barbuy, B, et al.
Publicado: (1992)

Stopping powers and ranges for protons and alpha particles
por: International Commission on Radiation Units and Measurements. Bethesda
Publicado: (1993)

Geometric effects in $\alpha$ particle detection from distributed air sources
por: Gil, L R, et al.
Publicado: (1994)

Evaluation of $\gamma$ and $\alpha$ doses due to natural radioactivity of building materials
por: Bruzzi, L, et al.
Publicado: (1993)

Measurement of the responses of small lithium glass scintillators to protons, deuterons and alpha particles
por: Dalton, A W
Publicado: (1987)

Production, isolation and characterization of radiochemically pure 163Ho samples for the ECHo-project
por: Dorrer, Holger, et al.
Publicado: (2018)

Reliability and radiation effects in compound semiconductors
por: Johnston, Allan
Publicado: (2010)

Development and optimization of targeted radionuclide tumor therapy using folate based radiopharmaceuticals
por: Reber, Josefine Astrid
Publicado: (2015)

Decay chain $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm
por: Cabrera, J A, et al.
Publicado: (1991)

Evidence of dark matter from biological observations?
por: Zioutas, Konstantin
Publicado: (1989)

Visualization of volumetric structures from MR images of the brain
por: Parvin, B, et al.
Publicado: (1995)

Study of $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm decay chain
por: Cabrera, J A, et al.
Publicado: (1992)

Study of an Air Curtain in the Context of Individual Protection from Exposure to Coronavirus (SARS-CoV-2) Contained in Cough-Generated Fluid Particles
por: Sakharov, Alexandre, et al.
Publicado: (2020)

NATO International Workshop on Coping and Health
por: Levine, Seymour, et al.
Publicado: (1980)

Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with $^{155}$Tb
por: Jakobsson, Ulrika, et al.
Publicado: (2020)

The vital balance: the life process in mental health and illness
por: Menninger, Karl
Publicado: (1963)

Applied dosimetry
por: Aglintsev, Konstantin Konstantinovich, et al.
Publicado: (1965)

(47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
por: Domnanich, Katharina A., et al.
Publicado: (2017)

Conference on Energy and the Environment Cost-benefit Analysis
por: Karam, Ratib Abraham, et al.
Publicado: (1976)

Principles of radiation protection: a textbook of health physics
por: Turner, James Edward, et al.
Publicado: (1967)

The self and its brain
por: Popper, Karl Raimund, et al.
Publicado: (1977)

Image Reconstruction Analysis for Positron Emission Tomography With Heterostructured Scintillators
por: Mohr, Philipp, et al.
Publicado: (2023)

Die natürliche Strahlenexposition des Menschen: Grundlage zur Beurteilung des Strahlenrisikos
por: Bücker, H, et al.
Publicado: (1974)

Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN
por: Webster, Ben, et al.
Publicado: (2019)

Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN
por: Webster, Ben, et al.
Publicado: (2019)

Preclinical in vivo application of $^{152}$Tb-DOTANOC: a radiolanthanide for PET imaging
por: Müller, Cristina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2vub7ov39ibhvqfseivr2o834u